Xconomy | Boston - Business + Technology in the Exponential Economy

Brightcove Bonds With AOL, Faces Competition With Akamai; Fidelity Backs EnVivo; Dyax to Sell Up To $50M in Stock; & More Boston-Area Deals News
Sirtris Shifts Focus From Resveratrol, Merck Shifts People From Seattle to Boston, Epix Shifts Into Cost-Saving Mode, & More Boston-Area Life Sciences News
Proteostasis Therapeutics Procures $45M, Stealthy Startup Gets Serious About Shampoo, MA Life Sciences Center Chief Shares Her Plans, & More Life Sciences News
Takeda Hands $20M Over to Alnylam, Skyhook Helps Mozilla Find its Way, Nuance Nabs Nokia Agreement, & More Boston-Area Deals News
Globespan Helps Fund COPAN

HC Ventures Leads $28M Round for InfaCare

HealthCare Ventures, a Cambridge, MA-based venture firm, has led a $28 million Series B round of financing for InfaCare Pharmaceueticals, of Trevose, PA, which is developing an experimental drug intended to prevent newborns from developing a blood condition linked to neurological problems, the company announced. Other backers in the round included repeat investor Atlas Venture, which has an office in Waltham, MA; new investor Longitude Capital, which has an operation in Greenwich, CT; and previous investor FirstMark Capital, of New York, NY.

Ryan McBride is Xconomy's correspondent. You can reach him at rmcbride@xconomy.com, or follow him on Twitter at http://twitter.com/Ryan_McBride.

Comments | Reprints | Share: